Immunological relationship between plasminogen activator inhibitors from different sources

Area of Science:

• Biochemistry
• Immunology
• Molecular Biology

Background:

• Tissue plasminogen activator (t-PA) is crucial for fibrinolysis.
• PA-inhibitor (PAI) regulates t-PA activity, impacting hemostasis.
• Understanding PAI's various forms is essential for clinical applications.

Purpose of the Study:

• To develop a radioimmunoassay for quantifying PA-inhibitor antigen.
• To investigate the immunological relationship of PA-inhibitors from different human sources.
• To assess the activity and antigen ratio of PA-inhibitors in various biological samples.

Main Methods:

• Raising polyclonal antibodies against human plasma PA-inhibitor.
• Developing a radioimmunoassay for PA-inhibitor antigen quantitation.
• Utilizing polyclonal antiserum and monoclonal antibodies for immunological studies.
• Performing immunoadsorption and competitive radioimmunoassays.

Main Results:

• PA-inhibitor antigen was quantifiable using radioimmunoassay.
• Significant variations in the ratio of PA-inhibitor activity to antigen were observed across plasma, serum, platelets, placenta, and cell lines.
• Plasma samples showed predominantly active PA-inhibitor, while other sources contained inactive forms.
• All PA-inhibitor sources were immunologically related and bound to antibodies, but active forms could not be eluted.

Conclusions:

• The developed radioimmunoassay is effective for PA-inhibitor antigen measurement.
• Human PA-inhibitors exhibit source-dependent variations in activity and antigen levels, indicating differential regulation.
• PA-inhibitors from various sources share close immunological similarities.